Your search returned 4 results.

Results
	1.	[Results of a post-marketing surveillance of meropenem administered over 2 g/day for serious infectious diseases]. [electronic resource] by Wakisaka, Koji Tani, Shunsuke Ishibashi, Kazuo Nukui, Kazuhiko Nagao, Munehiko Producer: 20160201 In: The Japanese journal of antibiotics vol. 68 Availability: No items available. Save to lists Add to cart (remove)
	2.	[Results of a post-marketing surveillance of meropenem for febrile neutropenia]. [electronic resource] by Wakisaka, Koji Tani, Shunsuke Ishibashi, Kazuo Nukui, Kazuhiko Nagao, Munehiko Producer: 20160107 In: The Japanese journal of antibiotics vol. 68 Availability: No items available. Save to lists Add to cart (remove)
	3.	Adding interferon to lamivudine enhances the early virologic response and reversion of the precore mutation in difficult-to-treat HBV infection. [electronic resource] by Yuki, Nobukazu Nagaoka, Takayuki Nukui, Kazuhiko Omura, Masao Hikiji, Kazumasa Kato, Michio Producer: 20081022 In: Journal of gastroenterology vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study. [electronic resource] by Ishimitsu, Toshihiko Fukuda, Hirofumi Uchida, Masako Ishibashi, Kazushi Sato, Fusako Nukui, Kazuhiko Nagao, Munehiko Producer: 20160826 In: Clinical and experimental hypertension (New York, N.Y. : 1993) vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)